AR072101A1 - Derivados azabiciclicos, su procedimiento de preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por los sistemas histaminergicos. - Google Patents
Derivados azabiciclicos, su procedimiento de preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por los sistemas histaminergicos.Info
- Publication number
- AR072101A1 AR072101A1 ARP090102108A ARP090102108A AR072101A1 AR 072101 A1 AR072101 A1 AR 072101A1 AR P090102108 A ARP090102108 A AR P090102108A AR P090102108 A ARP090102108 A AR P090102108A AR 072101 A1 AR072101 A1 AR 072101A1
- Authority
- AR
- Argentina
- Prior art keywords
- contain
- treatment
- pharmaceutical compositions
- linear
- branched
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Abstract
Un procedimiento para su preparacion, composiciones farmaceuticas que los contienen y uso de estas en el tratamiento de enfermedades del SNC, respiratorias y de la obesidad. Reivindicacion 1: Compuestos de formula (1) en la que ALK representa una cadena alquileno, W representa un grupo elegido entre -N(R')-C(=O)-( R) o (=O)-C-N(R')( R) en el que R y R' representan independientemente el uno del otro un hidrogeno o un grupo alquilo C1-6 lineal o ramificado sustituido opcionalmente con uno o varios grupos elegidos entre halogeno, hidroxi o alcoxi, entendiendose que: el termino alquileno designa un radical bivalente, lineal o ramificado, que contiene de 2 a 6 tomos de carbono, el termino alcoxi designa un grupo alquil-oxi cuya cadena alquilo, lineal o ramificada, contiene de 1 a 6 tomos de carbono, sus enantiomeros y diastereoisomeros, as¡ como sus sales de adicion a un cido o a una base farmaceuticamente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0803297A FR2932479A1 (fr) | 2008-06-13 | 2008-06-13 | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR072101A1 true AR072101A1 (es) | 2010-08-04 |
Family
ID=40227963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090102108A AR072101A1 (es) | 2008-06-13 | 2009-06-11 | Derivados azabiciclicos, su procedimiento de preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por los sistemas histaminergicos. |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US7906547B2 (es) |
| EP (1) | EP2133333A1 (es) |
| JP (1) | JP2009298790A (es) |
| KR (1) | KR20090129958A (es) |
| CN (1) | CN101602706A (es) |
| AP (1) | AP2009004891A0 (es) |
| AR (1) | AR072101A1 (es) |
| AU (1) | AU2009202341A1 (es) |
| BR (1) | BRPI0902395A2 (es) |
| CA (1) | CA2668527A1 (es) |
| CL (1) | CL2009001377A1 (es) |
| CO (1) | CO6190096A1 (es) |
| CR (1) | CR10844A (es) |
| EA (1) | EA200900692A1 (es) |
| EC (1) | ECSP099396A (es) |
| FR (1) | FR2932479A1 (es) |
| GT (1) | GT200900150A (es) |
| MA (1) | MA31141B1 (es) |
| MX (1) | MX2009005891A (es) |
| MY (1) | MY144748A (es) |
| NI (1) | NI200900114A (es) |
| NZ (1) | NZ577438A (es) |
| PE (1) | PE20091961A1 (es) |
| SG (1) | SG158015A1 (es) |
| SV (1) | SV2009003292A (es) |
| TW (1) | TW201000101A (es) |
| UY (1) | UY31857A1 (es) |
| WO (1) | WO2009150331A1 (es) |
| ZA (1) | ZA200903939B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10892398B2 (en) * | 2019-03-28 | 2021-01-12 | Johannes Pollanen | Qubit hardware for electrons on helium |
| WO2022113008A1 (en) | 2020-11-27 | 2022-06-02 | Richter Gedeon Nyrt. | Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6515013B2 (en) * | 2000-07-13 | 2003-02-04 | Abbott Laboratories | 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| WO2004052857A1 (en) * | 2002-12-10 | 2004-06-24 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists |
| FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP1707203A1 (en) * | 2005-04-01 | 2006-10-04 | Bioprojet | Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3- receptor ligands |
| KR100969402B1 (ko) * | 2005-04-08 | 2010-07-14 | 화이자 프로덕츠 인크. | Ｉ형 글리신 수송 억제제로서의 비시클릭 [3.1.0]헤테로아릴 아미드 |
| EP1842846A1 (en) * | 2006-04-07 | 2007-10-10 | Santhera Pharmaceuticals (Schweiz) AG | Phenylpiperidine derivatives as melanocortin-4 receptor modulators |
| GB2454615A (en) * | 2006-07-21 | 2009-05-13 | Lupin Ltd | Antidiabetic azabicyclo (3.1.0) hexan compounds |
-
2008
- 2008-06-13 FR FR0803297A patent/FR2932479A1/fr not_active Withdrawn
-
2009
- 2009-05-29 UY UY031857A patent/UY31857A1/es not_active Application Discontinuation
- 2009-05-29 SG SG200903642-7A patent/SG158015A1/en unknown
- 2009-06-01 PE PE2009000758A patent/PE20091961A1/es not_active Application Discontinuation
- 2009-06-03 GT GT200900150A patent/GT200900150A/es unknown
- 2009-06-03 MY MYPI20092264A patent/MY144748A/en unknown
- 2009-06-04 MX MX2009005891A patent/MX2009005891A/es not_active Application Discontinuation
- 2009-06-04 NZ NZ577438A patent/NZ577438A/en not_active IP Right Cessation
- 2009-06-05 ZA ZA200903939A patent/ZA200903939B/en unknown
- 2009-06-08 AP AP2009004891A patent/AP2009004891A0/xx unknown
- 2009-06-08 CR CR10844A patent/CR10844A/es not_active Application Discontinuation
- 2009-06-08 CL CL2009001377A patent/CL2009001377A1/es unknown
- 2009-06-09 NI NI200900114A patent/NI200900114A/es unknown
- 2009-06-09 EC EC2009009396A patent/ECSP099396A/es unknown
- 2009-06-10 AU AU2009202341A patent/AU2009202341A1/en not_active Abandoned
- 2009-06-10 SV SV2009003292A patent/SV2009003292A/es unknown
- 2009-06-11 AR ARP090102108A patent/AR072101A1/es unknown
- 2009-06-11 WO PCT/FR2009/000696 patent/WO2009150331A1/fr active Application Filing
- 2009-06-11 EA EA200900692A patent/EA200900692A1/ru unknown
- 2009-06-11 EP EP09290432A patent/EP2133333A1/fr not_active Withdrawn
- 2009-06-12 CO CO09061577A patent/CO6190096A1/es not_active Application Discontinuation
- 2009-06-12 JP JP2009140660A patent/JP2009298790A/ja not_active Withdrawn
- 2009-06-12 US US12/456,165 patent/US7906547B2/en not_active Expired - Fee Related
- 2009-06-12 KR KR1020090052291A patent/KR20090129958A/ko not_active Application Discontinuation
- 2009-06-12 MA MA31986A patent/MA31141B1/fr unknown
- 2009-06-12 CA CA002668527A patent/CA2668527A1/fr not_active Abandoned
- 2009-06-12 TW TW098119836A patent/TW201000101A/zh unknown
- 2009-06-15 CN CNA2009101459752A patent/CN101602706A/zh active Pending
- 2009-06-15 BR BRPI0902395-0A patent/BRPI0902395A2/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009202341A1 (en) | 2010-01-07 |
| NZ577438A (en) | 2010-09-30 |
| KR20090129958A (ko) | 2009-12-17 |
| GT200900150A (es) | 2011-08-25 |
| ECSP099396A (es) | 2010-01-29 |
| CA2668527A1 (fr) | 2009-12-13 |
| MX2009005891A (es) | 2010-02-17 |
| SV2009003292A (es) | 2010-02-01 |
| PE20091961A1 (es) | 2010-01-23 |
| CN101602706A (zh) | 2009-12-16 |
| NI200900114A (es) | 2010-02-03 |
| JP2009298790A (ja) | 2009-12-24 |
| US7906547B2 (en) | 2011-03-15 |
| WO2009150331A1 (fr) | 2009-12-17 |
| TW201000101A (en) | 2010-01-01 |
| CR10844A (es) | 2009-07-23 |
| ZA200903939B (en) | 2010-04-28 |
| EA200900692A1 (ru) | 2009-12-30 |
| SG158015A1 (en) | 2010-01-29 |
| CL2009001377A1 (es) | 2010-05-28 |
| AP2009004891A0 (en) | 2009-06-30 |
| FR2932479A1 (fr) | 2009-12-18 |
| EP2133333A1 (fr) | 2009-12-16 |
| US20090312389A1 (en) | 2009-12-17 |
| BRPI0902395A2 (pt) | 2010-04-20 |
| MY144748A (en) | 2011-10-31 |
| CO6190096A1 (es) | 2010-08-19 |
| MA31141B1 (fr) | 2010-02-01 |
| UY31857A1 (es) | 2009-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2008002768A1 (es) | Compuestos derivados de carboxiciclopropil-(bis-fenil-oxamidas); composicion farmaceutica que los contiene; procedimiento para la elaboracion de las composiciones y el uso de los compuestos en el tratamiento de diabetes y trastornos del sncentre otras enfermedades. | |
| UY30498A1 (es) | Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones | |
| CO6361937A2 (es) | Derivados de heteroaril amidas y sus usos como activadores de glucoquinasa | |
| AR067779A1 (es) | Profarmacos dipeptoides y su uso | |
| UY32793A (es) | Compuestos inhibidores de los virus flaviviridae, composición farmacéutica que los contiene y sus usos | |
| AR056873A1 (es) | Derivados de pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina, composiciones farmaceuticas | |
| UY29360A1 (es) | Nuevos derivados de pirazol, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones. | |
| GT200600117A (es) | Nuevos compuestos farmaceuticos | |
| CL2012002319A1 (es) | Compuestos derivados de amino-tienopirimidinas que contienen un grupo alquilo sustituido, inhibidores de mnk| o mnk2; composición farmacéutica; y su uso para la profilaxis o la terapia de enfermedades metabólicas, trastornos hematopoyéticos, enfermedades neurodegenerativas, cáncer, entre otras. | |
| CO6321248A2 (es) | Derivados de triazol utiles para el tratamiento de enfermedades | |
| ECSP088854A (es) | Moduladores bencimidazolicos de vr1 | |
| UY32315A (es) | Compuestos de piperidina y usos de los mismo-596 | |
| CU24030B1 (es) | Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen | |
| CU23761B7 (es) | Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| CR20140412A (es) | Inhibidores de la metalproteinasa matriz | |
| ECSP10010167A (es) | Composiciones oftálmicas novedosas | |
| AR079050A1 (es) | Compuestos benzoimidazolicos y sus usos | |
| AR076263A1 (es) | Composiciones y metodos para tratar cancer. uso. | |
| AR076181A1 (es) | Compuestos derivados de mentol y uso de los mismos como agentes activos orales y sistemicos. metodo. composicion. | |
| AR085428A1 (es) | (3r,4r)-4-ciano-3,4-difenilbutanoatos sustituidos, procedimiento para su preparacion y su uso como herbicidas y reguladores de crecimiento de plantas | |
| AR072101A1 (es) | Derivados azabiciclicos, su procedimiento de preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por los sistemas histaminergicos. | |
| AR077429A1 (es) | Compuestos hidroxiasenapina sus derivados y composiciones farmaceuticas que comprenden los mismos | |
| AR079267A1 (es) | Derivados del tipo hexahidrociclopenta(b)pirrol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| CR11860A (es) | Derivados de dibenzotiazepina y sus usos - 424 | |
| AR078094A1 (es) | Octasacaridos n-acilos activadores de los receptores de los fgf, su preparacion y su aplicacion en terapeutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |